Your browser doesn't support javascript.
loading
Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas.
Yeboa, Debra Nana; Yu, James B; Liao, Eric; Huse, Jason; Penas-Prado, Marta; Kann, Benjamin H; Sulman, Erik; Grosshans, David; Contessa, Joseph.
Affiliation
  • Yeboa DN; MD Anderson Cancer Center, Division of Radiation Oncology, Houston, TX, United States.
  • Yu JB; MD Anderson Cancer Center, Health Services Department, Houston, TX, United States.
  • Liao E; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, United States.
  • Huse J; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT, United States.
  • Penas-Prado M; MD Anderson Cancer Center, Health Services Department, Houston, TX, United States.
  • Kann BH; MD Anderson Cancer Center, Department of Pathology, Houston, TX, United States.
  • Sulman E; National Institute of Health, Neuro-Oncology Branch, Bethesda, MD, United States.
  • Grosshans D; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, United States.
  • Contessa J; New York University, Radiation Oncology Department, New York, NY, United States.
Clin Transl Radiat Oncol ; 15: 46-52, 2019 Feb.
Article in En | MEDLINE | ID: mdl-30656222

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Clin Transl Radiat Oncol Year: 2019 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Clin Transl Radiat Oncol Year: 2019 Type: Article Affiliation country: United States